ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print December 20, 2006, 10.1183/09031936.00001006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fenoglio, C-M.
Right arrow Articles by Dalphin, J-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fenoglio, C-M.
Right arrow Articles by Dalphin, J-C.
Eur Respir J 2007; 29:706-712
Copyright ©ERS Journals Ltd 2007

Diagnostic value of serum precipitins to mould antigens in active hypersensitivity pneumonitis

C-M. Fenoglio1,2, G. Reboux2,3, B. Sudre2,3, M. Mercier1,2, S. Roussel2,3, J-F. Cordier4, R. Piarroux2,3 and J-C. Dalphin2,5

1 Dept of Biostatistics, University of Franche-Comte, and 2 SERF (Santé et Environnement Rural, University of Franche-Comté) Group 3 Dept of Mycology and 5 Dept of Respiratory Diseases, CHU Besançon, Besançon 4 GERM’O’P, Dept of Respiratory Diseases, Hôpital Louis Pradel, Lyon, France.

CORRESPONDENCE: G. Reboux, Dept of Mycology, Jean Minjoz University Hospital, Boulevard Fleming, 25030 Besançon Cedex, France. Fax: 33 381668914. E-mail: Gabriel.reboux{at}ufc-chu.univ-fcomte.fr

Keywords: Diagnosis, hypersensitivity pneumonitis, precipitins, prospective study, serology

Received: January 4, 2006
Accepted December 12, 2006

Serum precipitins have a controversial diagnostic value in hypersensitivity pneumonitis (HP). The present authors’ objective was to assess their diagnostic value by developing scores from a panel of specific antigens tested by two techniques (electrosyneresis and double diffusion) to discriminate active HP from other interstitial lung diseases.

Consecutive patients presenting with a condition for which HP was considered in the differential diagnosis were included in the study. All patients underwent the same standardised diagnostic procedure, including precipitin tests performed in routine conditions. Clinical manifestations, bronchoalveolar lavage and high-resolution computed tomography defined the presence or absence of HP. Receiver-operating characteristic curves and logistic regression were used to develop the serological scores.

A total of 122 patients (including 31 cases of HP) were included in the study. Five antigens from the panel were selected for the serological scores (Absidia corymbifera, Eurotium amstelodami, Wallemia sebi, Saccharopolyspora rectivirgula and mesophilic Streptomyces sp.). Electrosyneresis was more discriminative than the double-diffusion technique. Predictive negative values varied 81–88% and predictive positive values varied 71–75% for prevalence of HP 20–35%.

In conclusion, serological scores using a panel of relevant antigens may guide both biological and clinical practice in areas of high prevalence of hypersensitivity pneumonitis.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the European Respiratory Society.